Health Policy
Commentary
Human Papillomavirus Vaccination in LGBTQ Patients: The Need for Dermatologists on the Front Lines
The authors discuss HPV-related conditions for LGBTQ patients, barriers to vaccine administration, and the role of dermatologists in promoting an...
Feature
CDER chief reflects on advances in rare diseases
“People always call me fearless, but I feel like I just state the facts,” Dr. Janet Woodcock said.
Latest News
CDC flips, acknowledges aerosol spread of COVID-19
The update acknowledges the existence of some published reports showing limited, uncommon circumstances where people with COVID-19 infected others...
Latest News
Inside the flawed White House testing scheme that did not protect Trump
An early antigen test used by the White House was woefully inaccurate. But the new antigen test the White House is using has not been...
News
‘Celebration’ will be ‘short-lived’ if COVID vaccine rushed: Experts
US regulators eventually could safely approve vaccines for COVID-19 if the process is kept free of political pressure regarding time lines, study...
Commentary
Active Comparator Trial Designs Used to Promote Development of Innovative New Medications
Although some recent clinical trials in dermatology have included active comparators, many new medications continue to be introduced without any...
Latest News
CDC playbook prepares states for rollout of COVID-19 vaccine if one is approved
The agency has asked states to submit plans for vaccine distribution by mid-October.
Commentary
Without Ginsburg, judicial threats to the ACA, reproductive rights heighten
As Nicholas Bagley, a law professor at the University of Michigan who specializes in health issues, tweeted: “Among...
Latest News
HHS plan to improve rural health focuses on better broadband, telehealth services
The announcement includes technical initiatives, such as a contract to help clinics and hospitals integrate care.
News from the FDA/CDC
FDA expands remdesivir use for all COVID-19 hospitalized patients
An EUA of remdesivir issued in May allowed the drug to be used only for patients with severe COVID-19, specifically, COVID-19 patients with low...
News
Two PR employees at FDA fired after plasma therapy controversy
The warnings by two public relations experts at the FDA against overpromoting convalescent plasma as a treatment for COVID-19 reportedly led to...